|
Volumn 18, Issue 10, 2012, Pages 746-751
|
Clinical study of Western medicine combined with Chinese medicine based on syndrome differentiation in the patients with polarized hypertension
|
Author keywords
Chinese medicine; Isolated hypertension with low diastolic blood pressure; Low diastolic pressure; Polarized hypertension; Syndrome differentiation and treatment
|
Indexed keywords
AMLODIPINE BESYLATE;
CHINESE DRUG;
DENGZHAN SHENGMAI;
HYDROCHLOROTHIAZIDE PLUS IRBESARTAN;
HYPERTENSIVE AGENT;
IRBESARTAN;
SHIYIWEI SHENQI;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
ASTRAGALUS MEMBRANACEUS;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR DISEASE;
CHINESE MEDICINE;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DISEASE COURSE;
DIZZINESS;
DRUG EFFECT;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDEMA;
FEMALE;
FLUSHING;
GERIATRIC PATIENT;
GINSENG;
HEADACHE;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
INCIDENCE;
INTERVENTION STUDY;
MAJOR CLINICAL STUDY;
MALE;
OUTCOME ASSESSMENT;
POLARIZED HYPERTENSION;
PRIORITY JOURNAL;
PULSE PRESSURE;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STATISTICAL SIGNIFICANCE;
SYNDROME;
SYSTOLIC BLOOD PRESSURE;
SYSTOLIC HYPERTENSION;
WEAKNESS;
AGED;
AMLODIPINE;
ANTIHYPERTENSIVE AGENTS;
BIPHENYL COMPOUNDS;
BLOOD PRESSURE;
DIASTOLE;
DRUGS, CHINESE HERBAL;
FEMALE;
HUMANS;
HYPERTENSION;
MALE;
STROKE VOLUME;
SYNDROME;
TETRAZOLES;
|
EID: 84867323971
PISSN: 16720415
EISSN: 19930402
Source Type: Journal
DOI: 10.1007/s11655-012-1231-7 Document Type: Article |
Times cited : (8)
|
References (13)
|